[en] BACKGROUND: This study aimed to assess the state-of-the-art of antinuclear antibody (ANA) testing as practiced in the Belgian and Luxembourg laboratories, using the results obtained in the Belgian National External Quality Assessment Scheme from 2000 to 2005. METHODS: During this period, nine samples with different specificities were sent for analysis. Participants were surveyed for methodology used and were asked to report staining pattern and titer of ANAs. In 2002, an attempt was made to improve the comparability of quantitative ANA results by the provision of a commercial reference material and to relate observed differences to methodology. RESULTS: With one exception, all participants employed a microscope-based indirect immunofluorescence assay with human epithelial cell line 2 cells. Most laboratories were accurate in describing the pattern. The percentage of unacceptable answers was greater for samples with borderline levels of antibody and for samples showing a cytoplasmic pattern. An improvement in the detection of anticentromere antibodies was observed. For all samples, a wide range of titers was reported. The provision of the secondary reference preparation led to improved inter-laboratory concordance. Comparison of methodology variables revealed a correlation between unstandardized titers and the power of the lamp of the microscope and the use of a dark room. CONCLUSIONS: The EQAS results presented in this work provide valuable insights into the state of the art of ANA testing as practiced in the Belgian and Luxembourg Laboratories and illustrate the important value of a national EQAS for ANA testing as a tool to improve performance and interlaboratory comparability of laboratory results.
Disciplines :
General & internal medicine
Author, co-author :
Van Blerk, Marjan
Van Campenhout, Christel
Bossuyt, Xavier
Duchateau, Jean
Humbel, Rene
Servais, Genevieve
Tomasi, Jean*-Paul
Albert, Adelin ; Université de Liège - ULiège > Département des sciences de la santé publique > Informatique médicale et biostatistique
Coucke, Wim
Libeer, Jean*-Claude
Language :
English
Title :
Current practices in antinuclear antibody testing: results from the Belgian External Quality Assessment Scheme.
Nakamura RM, Tan EM. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases. Clin Lab Med 1992;12:1-23.
Von Mühlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995;24:323-58.
Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med 2000;124:71-81.
Egner W. The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 2000;53:424-32.
Griesmacher A, Peichl P. Autoantibodies associated with rheumatic diseases. Clin Chem Lab Med 2001;39:189-208.
Wiik AS. Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand J Rheumatol 2005;34:260-8.
Nossent H, Rekvig OP. Antinuclear antibody screening in this new millennium: farewell to the microscope? Scand J Rheumatol 2001;30:123-6.
Moroi Y, Peebles C, Fritzler MJ, Steigerwald J, Tan EM. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 1980;77:1627-31.
Tholen D, Lawson NS, Cohen T, Gilmore B. Proficiency test performance and experience with College of American Pathologists' programs. Arch Pathol Lab Med 1995;119:307-11.
Roberts-Thomson PJ, McEvoy R, Gale R, Jovanovich S, Bradley J. Quality assurance of immunodiagnostic tests in Australasia. Pathology 1991;23:125-9.
Nakamura RM, Bylund DJ, Tan EM. Current status of available standards for quality improvement of assays for detection of autoantibodies to nuclear and intracellular antigens. J Clin Lab Anal 1994;8:360-8.
Taylor RN, Fulford KM. Assessment of laboratory improvement by the Center for Disease Control Diagnostic Immunology Proficiency Testing Program. J Clin Microbiol 1981;13:356-68.
Nakamura RM, Rippey JH. Quality assurance and proficiency testing for autoantibodies to nuclear antigen. Arch Pathol Lab Med 1985;109:109-14.
Feltkamp TE, Klein F, Janssens MB. Standardisation of the quantitative determination of antinuclear antibodies (ANAs) with a homogeneous pattern. Ann Rheum Dis 1988;47:906-9.
Roberts-Thomson PJ, McEvoy R, Gale R, Jovanovich S, Bradley J. Quality assurance of immunodiagnostic tests in Australasia: II. Five year review. Asian Pac J Allergy Immunol 1993;11:29-37.
Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, et al. Range of antinuclear antibodies in 'healthy' individuals. Arthritis Rheum 1997;40:1601-11.
Hollingsworth PN, Bonifacio E, Dawkins RL. Use of a standard curve improves precision and concordance of antinuclear antibody measurement. J Clin Lab Immunol 1987;22:197-200.
Bizarro N, Tozzoli R, Tonutti E, Piazza A, Manoni F, Ghirardello A, et al. Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: a collaborative study with the biomedical industry. J Immunol Meth 1998;219:99-107.
Pham BN, Albarède S, Guyard A, Burg E, Maisonneuve P. Impact of external quality assessment on antinuclear antibody detection performance. Lupus 2005;14:113-9.
Humbel RL. Detection of antinuclear antibodies by immunofluorescence. In: Van Venrooij WJ, Maini RN, editors. Manual of biological markers of disease. Deventer: Kluwer, 1993;A2:1-16.
Feltkamp TE. Antinuclear antibody determination in a routine laboratory. Ann Rheum Dis 1996;55:723-7.
Molden DP, Nakamura RM, Tan EM. Standardization of the immunofluorescence test for autoantibody to nuclear antigens (ANA): use of reference sera of defined antibody specificity. Am J Clin Pathol 1984;82:57-66.
Jaskowski TD, Schroder C, Martins TB, Mouritsen CL, Litwin CM, Hill HR. Screening for antinuclear antibodies by enzyme immunoassay. Am J Clin Pathol 1996;105:468-73.
Emlen W, O'Neill L. Clinical significance of antinuclear antibodies. Comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays. Arthritis Rheum 1997;40:1612-8.
Gniewek RA, Sandbulte C, Fox PC. Comparison of antinuclear antibody testing methods by ROC analysis with reference to disease diagnosis. Clin Chem 1997;43:1987-9.
Homburger HA, Cahen YD, Griffiths J, Jacob GL. Detection of antinuclear antibodies. Comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods. Arch Pathol Lab Med 1998;122:993-9.
Olaussen E, Rekvig OP. Screening tests for antinuclear antibodies (ANA): selective use of central nuclear antigens as a rational basis for screening by ELISA. J Autoimmun 1999;13:95-102.
Tan EM, Smolen JS, McDougal JS, Butcher BT, Conn D, Dawkins R, et al. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. 1. Precision, sensitivity, and specificity. Arthritis Rheum 1999;42:455-64.
Reisner BS, DiBlasi J, Goel N. Comparison of an enzyme immunoassay to an indirect fluorescent immunoassay for the detection of antinuclear antibodies. Am J Clin Pathol 1999;111:503-6.
Bossuyt X. Evaluation of two automated enzyme immunoassays for detection of antinuclear antibodies. Clin Chem Lab Med 2000;38:1033-7.
Kern P, Kron M, Hiesche K. Measurement of antinuclear antibodies: assessment of different test systems. Clin Diagn Lab Immunol 2000;7:72-8.
Ulvestad E, Kanestrøm A, Madland TM, Thomassen E, Haga HJ, Vollset SE. Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice. Scand J Immunol 2000;52:309-15.
Bayer PM, Fabian B, Hübl W. Immunofluorescence assays (IFA) and enzyme-linked immunosorbent assays (ELISA) in autoimmune disease diagnostics - technique, benefits, limitations and applications. Scand J Clin Lab Invest 2001;61(Suppl 235):68-76.
Hayashi N, Kawamoto T, Mukai M, Morinobu A, Koshiba M, Kondo S, et al. Detection of antinuclear antibodies by use of an enzyme immunoassay with nuclear HEp-2 cell extract and recombinant antigens: comparison with immunofluorescence assay in 307 patients. Clin Chem 2001;47:1649-59.
Ulvestad E. Performance characteristics and clinical utility of a hybrid ELISA for detection of ANA. APMIS 2001;109:217-22.
Bernardini S, Infantino M, Bellincampi L, Nuccetelli M, Afeltra A, Iori R, et al. Screening of antinuclear antibodies: comparison between enzyme immunoassay based on nuclear homogenates, purified or recombinant antigens and immunofluorescence assay. Clin Chem Lab Med 2004;42:1155-60.
Fenger M, Wiik A, Høier-Madsen M, Lykkegaard JJ, Rozenfeld T, Hansen MS, et al. Detection of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis. Clin Chem 2004;50:2141-7.
Tonutti E, Bassetti D, Piazza A, Visentini D, Poletto M, Bassetto F, et al. Diagnostic accuracy of Elisa methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits. Autoimmunity 2004;37:171-6.
